“…The A/G148 polymorphism has been associated with variations in total and LDL-C levels, FPG levels, and birth weight (Hegele et al, 1997(Hegele et al, , 1998. The polymorphism at position 311 has been associated with coronary artery disease, ischemic stroke in patients with type 2 diabetes mellitus, late-onset Alzheimer's disease, and reduced bone mass in postmenopausal women (Kao et al, 2002;Chen et al, 2003;Yamada et al, 2003;Martinelli et al, 2004;Shi et al, 2004). Our study showed that the PON2 C allele is a significant risk factor for CAAD in the Xinjiang Han and Uighur people with hypertension.…”